Table 1 Baseline clinical characteristics of 51 patients with LA HSCC
N = 51 | % | |
|---|---|---|
Age (years) | ||
Median | 57.0 | |
Range | 35–69 | |
Sex | ||
Male | 51 | 100 |
Female | 0 | 0 |
Tumor site | ||
Pyriform sinus | 39 | 76.5 |
Postcricoid | 3 | 5.9 |
Posterior hypopharyngeal wall | 9 | 17.6 |
T stages 7th | ||
T3 | 26 | 51.0 |
T4 | 25 | 49.0 |
N stages 7th | ||
N0 | 1 | 2.0 |
N1 | 14 | 27.5 |
N2b | 20 | 39.2 |
N2c | 16 | 31.4 |
ENE | ||
ENE positive | 15 | 29.4 |
ENE negative | 36 | 70.6 |
Esophagus | ||
Involved | 17 | 33.3 |
No involved | 34 | 66.7 |
Thyroid cartilage | ||
Involved | 17 | 33.3 |
No involved | 34 | 66.7 |
Vocal cord mobility | ||
Mobility | 23 | 45.1 |
Impaired | 9 | 17.6 |
Fixation | 19 | 37.3 |
CPS | ||
<1 | 13 | 25.5 |
>1 | 8 | 15.7 |
Not available | 30 | 58.8 |
ECOG | ||
0 | 32 | 62.7 |
1 | 19 | 37.3 |
